breast cancer
Conditions
Interventions
[Device used] PAXMAN scalp cooling device (Century Medical Co., Ltd.) [Cooling time] About 3 and a half hours [Intervention period] Anthracycline 4 courses and taxane 4 courses are being administere
Sponsors
Showa University
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: 1) Patients histologically diagnosed with breast cancer 2) Women who are over 20 years old and under 60 years old 3) Patients who are scheduled to undergo chemotherapy and hair loss is predicted 4) Patients who have given their consent in writing 5) Patients who are scheduled to have 8 or more courses of chemotherapy including anthracycline and taxane anticancer drugs before or after surgery (weight loss is up to 25%)
Exclusion criteria
Exclusion criteria: 1) Patients with malignant blood disease 2) Patients with cold allergies 3) Patients with cold agglutinin disease 4) Patients with a tumor on the scalp 5) Patients receiving high-dose anticancer drugs as pretreatment for stem cell transplantation 6) Patients undergoing head radiation therapy
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Evaluation of hair loss at the end of chemotherapy and during chemotherapy (CTCAE ver.4.0) Hair loss of eyebrows and eyelashes Whether wearing a hat or wig | — |
Countries
Japan
Contacts
Public ContactNana Komatsu
Showa University Breast center
Outcome results
None listed